The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Gramont, A., Figer, A., Seymour, M., Homerin, M., Hmissi, A., Cassidy, J., Boni, C., Cortes-Funes, H., Cervantes, A., Freyer, G., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.2938 · Cited by 3,815
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
André, T., Boni, C., Mounedji-Boudiaf, L., Navarro, M., Tabernero, J., Hickish, T., Topham, C., Zaninelli, M., Clingan, P., Bridgewater, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032709 · Cited by 3,689
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma
Richardson, P. G., Sonneveld, P., Schuster, M. W., Irwin, D., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043445 · Cited by 2,491
Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
Cunningham, D., Starling, N., Rao, S., Iveson, T., Nicolson, M., Coxon, F., Middleton, G., Daniel, F., Oates, J., & Norman, A. R. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa073149 · Cited by 2,285
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J.-L., Dmoszynska, A., Miguel, J. S., Hellmann, A., Facon, T., Foà, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070594 · Cited by 1,450
Giacchetti, S., Perpoint, B., Zidani, R., Le Bail, N., Faggiuolo, R., Focan, C., Chollet, P., Llory, J. F., Letourneau, Y., Coudert, B., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.1.136 · Cited by 1,403
Lenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Weber, D. M., Chen, C., Niesvizky, R., Wang, M., Belch, A., Stadtmauer, E. A., Siegel, D., Borrello, I., Rajkumar, S. V., Chanan-Khan, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070596 · Cited by 1,233
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer
Sparano, J. A., Wang, M., Martino, S., Jones, V., Perez, E. A., Saphner, T., Wolff, A. C., Sledge, G. W., Wood, W. C., & Davidson, N. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707056 · Cited by 997
Louvet, C., Labianca, R., Hammel, P., Lledo, G., Zampino, M. G., André, T., Zaniboni, A., Ducreux, M., Aitini, E., Taïeb, J., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.023 · Cited by 950
Cassidy, J., Clarke, S., Díaz-Rubio, E., Scheithauer, W., Figer, A., Wong, R., Koski, S., Lichinitser, M., Yang, T.-S., Rivera, F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9898 · Cited by 862
Tournigand, C., Cervantes, A., Figer, A., Lledo, G., Flesch, M., Buyse, M., Mineur, L., Carola, E., Etienne, P.-L., Rivera, F., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0106 · Cited by 805
Al-Batran, S.-E., Hartmann, J. T., Probst, S., Schmalenberg, H., Hollerbach, S., Hofheinz, R., Rethwisch, V., Seipelt, G., Homann, N., Wilhelm, G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9378 · Cited by 782
Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag, D. M., McQueney, P. A., Zhu, J., Hensens, O. D., Koupal, L. R., Liesch, J. M., Goetz, M., Lazarides, E., & Woods, C. M. (1995) · PubMed · Cited by 685
Richardson, P. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D. S., Irwin, D., Schuster, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 649
Rothenberg, M. L., Oza, A. M., Bigelow, R. H., Berlin, J. D., Marshall, J. L., Ramanathan, R. K., Hart, L. L., Gupta, S., Garay, C. A., Burger, B. G., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.11.126 · Cited by 646
Vasey, P. A., Jayson, G. C., Gordon, A., Gabra, H., Coleman, R., Atkinson, R., Parkin, D., Paul, J., Hay, A., Kaye, S. B., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh323 · Cited by 632
GERTH, K., BEDORF, N., HÖFLE, G., IRSCHIK, H., & REICHENBACH, H. (1996) · The Journal of Antibiotics · doi:10.7164/antibiotics.49.560 · Cited by 631
Chemotherapy‐induced neuropathy
Windebank, A. J., & Grisold, W. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00156.x · Cited by 613
Platinum neurotoxicity pharmacogenetics
McWhinney, S. R., Goldberg, R. M., & McLeod, H. L. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0840 · Cited by 574
Fleming, G. F., Brunetto, V. L., Cella, D., Look, K. Y., Reid, G. C., Munkarah, A. R., Kline, R., Burger, R. A., Goodman, A., & Burks, R. T. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.184 · Cited by 565
Wozniak, A. J., Crowley, J. J., Balcerzak, S. P., Weiss, G. R., Spiridonidis, C. H., Baker, L. H., Albain, K. S., Kelly, K., Taylor, S. A., Gandara, D. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2459 · Cited by 555
Richardson, P. G., Blood, E., Mitsiades, C. S., Jagannath, S., Zeldenrust, S. R., Alsina, M., Schlossman, R. L., Rajkumar, S. V., Desikan, K. R., Hideshima, T., et al. (2006) · Blood · doi:10.1182/blood-2006-04-015909 · Cited by 523
Kowalski, R. J., Giannakakou, P., & Hamel, E. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.4.2534 · Cited by 511
Thomas, E. S., Gomez, H. L., Li, R. K., Chung, H.-C., Fein, L. E., Chan, V. F., Jassem, J., Pivot, X. B., Klimovsky, J. V., de Mendoza, F. H., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.6557 · Cited by 481
Peripheral Neuropathy Induced by Microtubule-Stabilizing Agents
Lee, J. J., & Swain, S. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0543 · Cited by 472
Kemp, G., Rose, P., Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley, H., Belpomme, D., & Glick, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2101 · Cited by 463
Poplin, E., Feng, Y., Berlin, J., Rothenberg, M. L., Hochster, H., Mitchell, E., Alberts, S., O'Dwyer, P., Haller, D., Catalano, P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.9007 · Cited by 438
Argyriou, A. A., Iconomou, G., & Kalofonos, H. P. (2008) · Blood · doi:10.1182/blood-2008-04-149385 · Cited by 432
Self-citationThomas, E. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5019 · Cited by 428
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
Thompson, S. W., Davis, L. E., Kornfeld, M., Hilgers, R. D., & Standefer, J. C. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7<1269::aid-cncr2820540707>3.0.co;2-9 · Cited by 394
Perez, E. A., Lerzo, G., Pivot, X., Thomas, E., Vahdat, L., Bosserman, L., Viens, P., Cai, C., Mullaney, B., Peck, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.3849 · Cited by 393
Calhoun, E. A., Welshman, E. E., Chang, C.-H., Lurain, J. R., Fishman, D. A., Hunt, T. L., & Cella, D. (2003) · International Journal of Gynecological Cancer · doi:10.1111/j.1525-1438.2003.13603.x · Cited by 392
Mateos, M.-V., Hernández, J.-M., Hernández, M.-T., Gutiérrez, N.-C., Palomera, L., Fuertes, M., Díaz-Mediavilla, J., Lahuerta, J.-J., de la Rubia, J., Terol, M.-J., et al. (2006) · Blood · doi:10.1182/blood-2006-04-019778 · Cited by 389
Stoehlmacher, J. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.12.936 · Cited by 384
Peripheral sensory neuropathy and cisplatin chemotherapy
Roelofs, R. I., Hrushesky, W., Rogin, J., & Rosenberg, L. (1984) · Neurology · doi:10.1212/wnl.34.7.934 · Cited by 370
Chaudhry, V., Rowinsky, E. K., Sartorius, S. E., Donehower, R. C., & Cornblath, D. R. (1994) · Annals of Neurology · doi:10.1002/ana.410350310 · Cited by 363
Gregg, R. W., Molepo, J. M., Monpetit, V. J., Mikael, N. Z., Redmond, D., Gadia, M., & Stewart, D. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.795 · Cited by 358
Grolleau, F., Gamelin, L., Boisdron-Celle, M., Lapied, B., Pelhate, M., & Gamelin, E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.5.2293 · Cited by 344
A review on oxaliplatin-induced peripheral nerve damage
Argyriou, A. A., Polychronopoulos, P., Iconomou, G., Chroni, E., & Kalofonos, H. P. (2008) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.01.003 · Cited by 330
Self-citationTa, L. E., Espeset, L., Podratz, J., & Windebank, A. J. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.04.010 · Cited by 325
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Richardson, P. G., Sonneveld, P., Schuster, M. W., Stadtmauer, E. A., Facon, T., Harousseau, J., Ben‐Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07573.x · Cited by 305
Vincristine‐induced neuropathy: A clinical study of fifty leukemic patients
Sandier, S. G., Tobin, W., & Henderson, E. S. (1969) · Neurology · doi:10.1212/wnl.19.4.367 · Cited by 300
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub4 · Cited by 298
Self-citationVINCRISTINE NEUROPATHY: CLINICAL AND ELECTROPHYSIOLOGICAL OBSERVATIONS
CASEY, E. B., JELLIFE, A. M., LE QUESNE, P. M., & MILLETT, Y. L. (1973) · Brain · doi:10.1093/brain/96.1.69 · Cited by 293
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F., & Lersch, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00667-1 · Cited by 290
Thomas, E., Tabernero, J., Fornier, M., Conté, P., Fumoleau, P., Lluch, A., Vahdat, L. T., Bunnell, C. A., Burris, H. A., Viens, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9102 · Cited by 290
Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian Cancer
van der Hoop, R. G., Vecht, C. J., van der Burg, M. E. L., Elderson, A., Boogerd, W., Heimans, J. J., Vries, E. P., van Houwelingen, J. C., Jennekens, F. G. I., Gispen, W. H., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220204 · Cited by 287
Effects of different schedules of oxaliplatin treatment on the peripheral nervous system of the rat
Cavaletti, G., Tredici, G., Petruccioli, M. G., Dondè, E., Tredici, P., Marmiroli, P., Minoia, C., Ronchi, A., Bayssas, M., & Griffon Etienne, G. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00300-8 · Cited by 281
Self-citationGill, J. S., & Windebank, A. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1130 · Cited by 278
Cavaletti, G., Frigeni, B., Lanzani, F., Mattavelli, L., Susani, E., Alberti, P., Cortinovis, D., & Bidoli, P. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2009.12.008 · Cited by 274
Self-citationRichardson, P. G., Xie, W., Mitsiades, C., Chanan-Khan, A. A., Lonial, S., Hassoun, H., Avigan, D. E., Oaklander, A. L., Kuter, D. J., Wen, P. Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3087 · Cited by 274
Koss, M. N., Hochholzer, L., & O’Leary, T. J. (1991) · Cancer · doi:10.1002/1097-0142(19910501)67:9<2241::aid-cncr2820670905>3.0.co;2-a · Cited by 272
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Bokemeyer, C., Berger, C. C., Kuczyk, M. A., & Schmoll, H. J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.11.2923 · Cited by 268
Ruzzo, A., Graziano, F., Loupakis, F., Rulli, E., Canestrari, E., Santini, D., Catalano, V., Ficarelli, R., Maltese, P., Bisonni, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1844 · Cited by 266
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
Cavaletti, G., Gilardini, A., Canta, A., Rigamonti, L., Rodriguez-Menendez, V., Ceresa, C., Marmiroli, P., Bossi, M., Oggioni, N., D'Incalci, M., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.010 · Cited by 265
Self-citationAllegra, C. J., Yothers, G., O'Connell, M. J., Sharif, S., Colangelo, L. H., Lopa, S. H., Petrelli, N. J., Goldberg, R. M., Atkins, J. N., Seay, T. E., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9220 · Cited by 262
Sutton, G., Brunetto, V. L., Kilgore, L., Soper, J. T., McGehee, R., Olt, G., Lentz, S. S., Sorosky, J., & Hsiu, J.-G. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.6001 · Cited by 254
Peripheral nerve damage associated with administration of taxanes in patients with cancer
Argyriou, A. A., Koltzenburg, M., Polychronopoulos, P., Papapetropoulos, S., & Kalofonos, H. P. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.008 · Cited by 240
Self-citationLand, S. R., Kopec, J. A., Cecchini, R. S., Ganz, P. A., Wieand, H. S., Colangelo, L. H., Murphy, K., Kuebler, J. P., Seay, T. E., Needles, B. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.6652 · Cited by 239
Vincristine treatment of advanced cancer: a cooperative study of 392 cases.
Holland, J. F., Scharlau, C., Gailani, S. D., Krant, M. J., Olson, K. B., Horton, J., Shnider, B. I., Lynch, J. J., Owens, A. H., Carbone, P. P., et al. (1973) · PubMed · Cited by 233
Strumberg, D., Brügge, S., Korn, M. W., Koeppen, S., Ranft, J., Scheiber, G., Reiners, C., Möckel, C., Seeber, S., & Scheulen, M. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf058 · Cited by 232
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy
Park, S. B., Lin, C. S.-Y., Krishnan, A. V., Goldstein, D., Friedlander, M. L., & Kiernan, M. C. (2009) · Brain · doi:10.1093/brain/awp219 · Cited by 231
McDonald, E. S., Randon, K. R., Knight, A., & Windebank, A. J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.013 · Cited by 227
Gatzemeier, U., von Pawel, J., Gottfried, M., Velde, G. P. M. T., Mattson, K., DeMarinis, F., Harper, P., Salvati, F., Robinet, G., Lucenti, A., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3390 · Cited by 226
Roché, H., Yelle, L., Cognetti, F., Mauriac, L., Bunnell, C., Sparano, J., Kerbrat, P., Delord, J.-P., Vahdat, L., Peck, R., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7535 · Cited by 224
Cisplatin neuropathy. Risk factors, prognosis, and protection by WR-2721
Mollman, J. E., Glover, D. J., Hogan, W. M., & FURMAN, R. E. (1988) · Cancer · doi:10.1002/1097-0142(19880601)61:11<2192::aid-cncr2820611110>3.0.co;2-a · Cited by 219
Badros, A., Goloubeva, O., Dalal, J. S., Can, I., Thompson, J., Rapoport, A. P., Heyman, M., Akpek, G., & Fenton, R. G. (2007) · Cancer · doi:10.1002/cncr.22921 · Cited by 217
Oxaliplatin‐induced neurotoxicity and the development of neuropathy
Krishnan, A. V., Goldstein, D., Friedlander, M., & Kiernan, M. C. (2005) · Muscle & Nerve · doi:10.1002/mus.20340 · Cited by 216
McLeod, H. L., Sargent, D. J., Marsh, S., Green, E. M., King, C. R., Fuchs, C. S., Ramanathan, R. K., Williamson, S. K., Findlay, B. P., Thibodeau, S. N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.7943 · Cited by 216
Lobert, S., Vulevic, B., & Correia, J. J. (1996) · Biochemistry · doi:10.1021/bi953037i · Cited by 212
Lecomte, T., Landi, B., Beaune, P., Laurent-Puig, P., & Loriot, M.-A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2076 · Cited by 211
Wang, W.-S., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J.-K., Wang, H.-S., Chiou, T.-J., Liu, J.-H., Yen, C.-C., & Chen, P.-M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-312 · Cited by 210
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial
Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., & Kalofonos, H. P. (2005) · Neurology · doi:10.1212/01.wnl.0000148609.35718.7d · Cited by 209
Self-citationPark, S., Krishnan, A., Lin, C., Goldstein, D., Friedlander, M., & Kiernan, M. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786848569 · Cited by 208
Landowski, T. H., Megli, C. J., Nullmeyer, K. D., Lynch, R. M., & Dorr, R. T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3684 · Cited by 202
Chou, T.-C., Zhang, X.-G., Balog, A., Su, D.-S., Meng, D., Savin, K., Bertino, J. R., & Danishefsky, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9642 · Cited by 198
Grothey, A., Nikcevich, D. A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Novotny, P. J., Chitaley, U., Alberts, S. R., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5911 · Cited by 198
Dose-related vincristine-induced peripheral neuropathy with unexpected off-therapy worsening
Verstappen, C. C. P., Koeppen, S., Heimans, J. J., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000154642.45474.28 · Cited by 196
Attal, N., Bouhassira, D., Gautron, M., Vaillant, J. N., Mitry, E., Lepère, C., Rougier, P., & Guirimand, F. (2009) · Pain · doi:10.1016/j.pain.2009.03.024 · Cited by 195
Rowinsky, E. K., Chaudhry, V, Forastiere, A. A., Sartorius, S. E., Ettinger, D. S., Grochow, L. B., Lubejko, B. G., Cornblath, D. R., & Donehower, R. C. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.10.2010 · Cited by 192
Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
Pace, A., Giannarelli, D., Galiè, E., Savarese, A., Carpano, S., Della Giulia, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5279e · Cited by 191
Topp, K. S., Tanner, K. D., & Levine, J. D. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000904)424:4<563::aid-cne1>3.0.co;2-u · Cited by 189
Tanner, K. D., Levine, J. D., & Topp, K. S. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980615)395:4<481::aid-cne5>3.0.co;2-y · Cited by 188
Bastuji-Garin, S., Ochonisky, S., Bouche, P., Gherardi, R. K., Duguet, C., Djerradine, Z., Poli, F., & Revuz, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2002.19502.x · Cited by 184
Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy
KWEEKEL, D., GELDERBLOM, H., & GUCHELAAR, H. (2005) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.12.006 · Cited by 179
Peters, C. M., Jimenez-Andrade, J. M., Kuskowski, M. A., Ghilardi, J. R., & Mantyh, P. W. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.066 · Cited by 175
Kottschade, L. A., Sloan, J. A., Mazurczak, M. A., Johnson, D. B., Murphy, B. P., Rowland, K. M., Smith, D. A., Berg, A. R., Stella, P. J., & Loprinzi, C. L. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-1018-3 · Cited by 173
Characteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy
Chaudhry, V., Cornblath, D. R., Polydefkis, M., Ferguson, A., & Borrello, I. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00193.x · Cited by 172
Cavaletti, G., Jann, S., Pace, A., Plasmati, R., Siciliano, G., Briani, C., Cocito, D., Padua, L., Ghiglione, E., Manicone, M., et al. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1085-9489.2006.00078.x · Cited by 170
Self-citationJin, H. W., Flatters, S. J. L., Xiao, W. H., Mulhern, H. L., & Bennett, G. J. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.11.001 · Cited by 167
Mohty, B., El-Cheikh, J., Yakoub-Agha, I., Moreau, P., Harousseau, J.-L., & Mohty, M. (2010) · Haematologica · doi:10.3324/haematol.2009.012674 · Cited by 167
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2000) · PubMed · Cited by 167
Self-citationDenduluri, N., Low, J. A., Lee, J. J., Berman, A. W., Walshe, J. M., Vatas, U., Chow, C. K., Steinberg, S. M., Yang, S. X., & Swain, S. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.0784 · Cited by 165
Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia
Ramchandren, S., Leonard, M., Mody, R. J., Donohue, J. E., Moyer, J., Hutchinson, R., & Gurney, J. G. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00230.x · Cited by 163
Quantitative Sensory Findings in Patients With Bortezomib-Induced Pain
Cata, J. P., Weng, H.-R., Burton, A. W., Villareal, H., Giralt, S., & Dougherty, P. M. (2007) · The Journal of Pain · doi:10.1016/j.jpain.2006.09.014 · Cited by 160
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.01008-5.x · Cited by 157
Self-citationLong term effects of vincristine on the peripheral nervous system
Postma, T. J., Benard, B. A., Huijgens, P. C., Ossenkoppele, G. J., & Heimans, J. J. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01050259 · Cited by 154
Maindrault‐Gœbel, F., de Gramont, A., Louvet, C., André, T., Carola, É., Mabro, M., Artru, P., Gilles-Amar, V., Lotz, J., Izrael, V., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00068-5 · Cited by 153
Glendenning, J., Barbáchano, Y., Norman, A. R., Dearnaley, D. P., Horwich, A., & Huddart, R. A. (2010) · Cancer · doi:10.1002/cncr.24981 · Cited by 153
Dzagnidze, A., Katsarava, Z., Makhalova, J., Liedert, B., Yoon, M., Kaube, H., Limmroth, V., & Thomale, J. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0523-07.2007 · Cited by 152
Smith, R. E., Brown, A. M., Mamounas, E. P., Anderson, S., Lembersky, B. C., Atkins, J. H., Shibata, H. R., Báez, L., DeFusco, P. A., Davila, E., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.11.3403 · Cited by 151
Gandara, D. R., Crowley, J. J., Livingston, R. B., Perez, E. A., Taylor, C. W., Weiss, G. R., Neefe, J. R., Hutchins, L. F., Roach, R. W., & Grunberg, S. M. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.5.873 · Cited by 150
Rodriguez, M. A., Pytlík, R., Kozák, T., Chhanabhai, M., Gascoyne, R. D., Lu, B., Deitcher, S. R., & Winter, J. N. (2009) · Cancer · doi:10.1002/cncr.24359 · Cited by 145
Sarris, A. H., Hagemeister, F. B., Romaguera, J. E., Rodríguez, M., McLaughlin, P. J., Tsimberidou, A. M., Medeiros, L. J., Samuels, B. I., Pate, O., Oholendt, M. S., et al. (2000) · Annals of Oncology · doi:10.1023/a:1008348010437 · Cited by 143
Thalidomide sensory neurotoxicity
Cavaletti, G., Beronio, A., Reni, L., Ghiglione, E., Schenone, A. E., Briani, C., Zara, G., Cocito, D., Isoardo, G., Ciaramitaro, P., et al. (2004) · Neurology · doi:10.1212/wnl.62.12.2291 · Cited by 135
Self-citationMcDonald, E. S., & Windebank, A. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0468 · Cited by 135
Jiang, Y., Guo, C., Vasko, M. R., & Kelley, M. R. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1173 · Cited by 135
Low toxicity and anticancer activity of a novel liposomal cisplatin (Lipoplatin) in mouse xenografts
Boulikas, T. (2004) · Oncology Reports · doi:10.3892/or.12.1.3 · Cited by 134
Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E Supplementation
Argyriou, A. A., Chroni, E., Koutras, A. K., Iconomou, G., Papapetropoulos, S., Polychronopoulos, P., & Kalofonos, H. P. (2006) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.03.013 · Cited by 134
Self-citationCartei, G., Cartei, F., Cantone, A., Causarano, D., Genco, G., Tobaldin, A., Interlandi, G., & Giraldi, T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.10.794 · Cited by 133
Persohn, E., Canta, A., Schoepfer, S., Traebert, M., Mueller, L., Gilardini, A., Galbiati, S., Nicolini, G., Scuteri, A., Lanzani, F., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.04.006 · Cited by 132
Self-citationVansteenkiste, J., Lara, P. N., Chevalier, T. L., Breton, J.-L., Bonomi, P., Sandler, A. B., Socinski, M. A., Delbaldo, C., McHenry, B. M., Lebwohl, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.7097 · Cited by 130
Shemesh, O. A., & Spira, M. E. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0586-0 · Cited by 128
Pharmacokinetics and adverse reactions of a new liposomal cisplatin (Lipoplatin): Phase I study
Stathopoulos, G. P., Boulikas, T., Vougiouka, M., Deliconstantinos, G., Rigatos, S., Darli, E., Viliotou, V., & Stathopoulos, J. (2005) · Oncology Reports · doi:10.3892/or.13.4.589 · Cited by 128
Cavaletti, G., Cavalletti, E., Montaguti, P., Oggioni, N., Negri, O. D., & Tredici, G. (1997) · PubMed · Cited by 124
Self-citationSouglakos, J., Mavroudis, D., Kakolyris, S., Kouroussis, C., Vardakis, N., Androulakis, N., Agelaki, S., Kalbakis, K., Tsetis, D. K., Athanasiadis, N., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.015 · Cited by 123
A Practical Update on the Use of Bortezomib in the Management of Multiple Myeloma
Miguel, J. F. S., Bladé, J., Boccadoro, M., Cavenagh, J. D., Glasmacher, A., Jagannath, S., Lonial, S., Orlowski, R. Z., Sonneveld, P., & Ludwig, H. (2006) · The Oncologist · doi:10.1634/theoncologist.11-1-51 · Cited by 120
Meregalli, C., Canta, A., Carozzi, V., Chiorazzi, A., Oggioni, N., Gilardini, A., Ceresa, C., Avezza, F., Crippa, L., Marmiroli, P., et al. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2009.07.001 · Cited by 119
Self-citationCavaletti, G., Marzorati, L., Bogliun, G., Colombo, N., Marzola, M. M., Pittelli, M., & Tredici, G. (1992) · Cancer · Cited by 116
Self-citationMauri, D. N., Kamposioras, K. V., Tsali, L., Bristianou, M., Valachis, A., Karathanasi, I., Georgiou, C., & Polyzos, N. P. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.006 · Cited by 116
Bruna, J., Udina, E., Alé, A., Vilches, J., Vynckier, A., Monbaliu, J. G., Silverman, L. R., & Navarro, X. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.02.006 · Cited by 115
Self-citationMaestri, A., Ceratti, A. D. P., Cundari, S., Zanna, C., Cortesi, E., & Crinò, L. (2005) · Tumori Journal · doi:10.1177/030089160509100206 · Cited by 113
Studies on the pathogenesis of vincristine‐induced neuropathy
Sahenk, Z., Brady, S. T., & Mendell, J. R. (1987) · Muscle & Nerve · doi:10.1002/mus.880100115 · Cited by 113
Phase II Genomics Study of Ixabepilone as Neoadjuvant Treatment for Breast Cancer
Baselga, J. M., Zambetti, M., Llombart‐Cussac, A., Manikhas, G., Kubista, E., Steger, G. G., Makhson, A. N., Tjulandin, S., Ludwig, H., Verrill, M. W., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2646 · Cited by 113
Dougherty, P. M., Cata, J. P., Burton, A. W., Vu, K., & Weng, H. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.08.006 · Cited by 110
Cisplatin neuropathy: clinical course and neurophysiological findings
LoMonaco, M., Milone, M., Batocchi, A. P., Padua, L., Restuccia, D., & Tonali, P. A. (1992) · Journal of Neurology · doi:10.1007/bf00839140 · Cited by 109
Role of MAPKs in platinum-induced neuronal apoptosis
Scuteri, A., Galimberti, A., Maggioni, D., Ravasi, M., Pasini, S., Nicolini, G., Bossi, M., Miloso, M., Cavaletti, G., & Tredici, G. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.01.003 · Cited by 109
Self-citationPersistent neuropathy after treatment with cisplatin and oxaliplatin
Brouwers, E. E. M., Huitema, A. D. R., Boogerd, W. J., Beijnen, J. H., & Schellens, J. H. M. (2009) · Acta Oncologica · doi:10.1080/02841860902806609 · Cited by 106
Persistent Mobility Disability After Neurotoxic Chemotherapy
Hile, E. S., Fitzgerald, G. K., & Studenski, S. A. (2010) · Physical Therapy · doi:10.2522/ptj.20090405 · Cited by 106
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
Meijer, C., de Vries, E. G. E., Marmiroli, P., Tredici, G., Frattola, L., & Cavaletti, G. (1999) · PubMed · Cited by 104
Self-citationInterventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub3 · Cited by 104
Self-citationHerbst, R. S., Mendolson, D. S., Ebbinghaus, S., Gordon, M. S., O'Dwyer, P. J., Lieberman, G. S., Ing, J., Kurzrock, R., Novotny, W. F., & Eckhardt, G. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.3013 · Cited by 103
Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma
Tosi, P., Zamagni, E., Cellini, C., Plasmati, R., Cangini, D., Tacchetti, P., Perrone, G., Pastorelli, F., Tura, S., Baccarani, M., et al. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00382.x · Cited by 98
Argyriou, A. A., Polychronopoulos, P., Koutras, A. K., Iconomou, G., Gourzis, P., Assimakopoulos, K., Kalofonos, H. P., & Chroni, E. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0868-6 · Cited by 95
Self-citationThalidomide Metabolism and Hydrolysis: Mechanisms and Implications
Lepper, E. R., Smith, N. F., Cox, M. C., Scripture, C. D., & Figg, W. D. (2006) · Current Drug Metabolism · doi:10.2174/138920006778017777 · Cited by 95
Argyriou, A. A., Polychronopoulos, P., Iconomou, G., Koutras, A. K., Makatsoris, T., Gerolymos, M. K., Gourzis, P., Assimakopoulos, K., Kalofonos, H. P., & Chroni, E. (2007) · Acta Oncologica · doi:10.1080/02841860701355055 · Cited by 93
Self-citationConlin, A. K., Seidman, A. D., Bach, A. M., Lake, D. E., Dickler, M. N., D’Andrea, G. M., Traina, T. A., Danso, M. A., Brufsky, A., Saleh, M. N., et al. (2010) · Clinical Breast Cancer · doi:10.3816/cbc.2010.n.036 · Cited by 91
Lobo, C. F., Lopes, G. D. L., Jr., Baez, O., Castrellon, A. B., Ferrell, A., Higgins, C., Hurley, E., Hurley, J. E., dos Reis, I. M., Richman, S. P., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1002-0 · Cited by 90
The proteasome: a novel target for anticancer therapy
Montagut, C. O., Rovira, A., & Albanell, J. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0176-8 · Cited by 87
Krarup‐Hansen, Rietz, Krarup, Heydorn, Rørth, & Schmalbruch (1999) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.1999.00160.x · Cited by 82
Moore, D. H., Donnelly, J. P., McGuire, W. P., Almadrones, L., Cella, D. F., Herzog, T. J., & Waggoner, S. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.086 · Cited by 80
Réa, D., Legros, L., Raffoux, E., Thomas, X., Turlure, P., Maury, S., Dupriez, B., Pigneux, A., Choufi, B., Reman, O., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404115 · Cited by 79
Casafont, Í., Berciano, M. T., & Lafarga, M. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9086-1 · Cited by 78
Krzakowski, M. J., Ramlau, R., Jassem, J., Szczęsna, A., Zatloukal, P., von Pawel, J., Sun, X.-S., Bennouna, J., Santoro, A., Biesma, B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4146 · Cited by 77
Chemotherapy-induced peripheral neuropathy.
Hilkens, P. H. E., & van den Bent, M. J. (1997) · PubMed · Cited by 75
Kornblith, A. B., Anderson, J. R., Cella, D. F., Tross, S., Zuckerman, E. L., Cherin, E., Henderson, E. S., Canellos, G. P., Kosty, M. P., Cooper, M. R., et al. (1992) · Cancer · Cited by 71
Velasco, R., Petit, J., Clapés, V., Verdú, E., Navarro, X., & Bruna, J. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00248.x · Cited by 70
Self-citationCisplatin induced neuropathy: Central, peripheral and autonomic nerve involvement
Boogerd, W. J., Huinink, W. W. T. B., Dalesio, O., Hoppenbrouwers, W. J. J. F., & van der Sande, J. J. (1990) · Journal of Neuro-Oncology · doi:10.1007/bf02341156 · Cited by 68
Fulminant demyelinating neuropathy mimicking cerebral death
Bakshi, N., Maselli, R. A., Gospe, S. M., Ellis, W. G., McDonald, C. M., & Mandler, R. N. (1997) · Muscle & Nerve · Cited by 66
Thalidomide neuropathy: clinical, electrophysiological and neuroradiological features
Isoardo, G., Bergui, M., Durelli, L., et al. (2003) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2003.00203.x · Cited by 64
Callizot, N., Andriambeloson, E., Glass, J. D., Revel, M., Ferro, P., Cirillo, R., Vitte, P., & Dréano, M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0689-7 · Cited by 63
Bunnell, C. A., Vahdat, L. T., Schwartzberg, L. S., Gralow, J. R., Klimovsky, J., Poulart, V., Peck, R., & Thomas, E. S. (2008) · Clinical Breast Cancer · doi:10.3816/cbc.2008.n.026 · Cited by 62
Wachters, F. M., van Putten, J. W. G., Kramer, H., Erjavec, Z., Eppinga, P., Strijbos, J. H., de Leede, G. P. J., Boezen, H. M., de Vries, E. G. E., & Groen, H. J. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601283 · Cited by 61
Ishibashi, K., Okada, N., Miyazaki, T., Sano, M., & Ishida, H. (2010) · International Journal of Clinical Oncology · doi:10.1007/s10147-009-0015-3 · Cited by 60
Zhang, H., Mizumachi, T., Cárcel‐Trullols, J., Li, L., Naito, A., Spencer, H. J., Spring, P. M., Smoller, B. R., Watson, A. J., Margison, G. P., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm072 · Cited by 60
Axonal tubulin and microtubules: morphologic evidence for stable regions on axonal microtubules
Sahenk, Z., & Brady, S. T. (1987) · Cell Motility · doi:10.1002/cm.970080207 · Cited by 59
Interventions for preventing neuropathy caused by cisplatin and related compounds
Albers, J. W., Chaudhry, V., Cavaletti, G., & Donehower, R. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005228.pub2 · Cited by 54
Self-citationArgyriou, A. A., Polychronopoulos, P., Koutras, A. K., XIROS, N., Petsas, T., Argyriou, K., Kalofonos, H. P., & Chroni, E. (2007) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2006.00718.x · Cited by 51
Self-citationQvortrup, C., Jensen, B. V., Fokstuen, T., Nielsen, S. E., Keldsen, N., Glimelius, B. L. G., Bjerregaard, B., Mejer, J., Larsen, F. O., & Pfeiffer, P. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp272 · Cited by 51
Beer, T. M., Higano, C. S., Saleh, M. N., Dreicer, R., Hudes, G. R., Picus, J., Rarick, M. U., Fehrenbacher, L., & Hannah, A. L. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9068-1 · Cited by 49
Huang, H., Menefee, M. E., Edgerly, M., Zhuang, S. H., Kotz, H. L., Poruchynsky, M. S., Huff, L. M., Bates, S. E., & Fojo, T. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0379 · Cited by 47
Kooten, B. V., van Diemen, H. A. M., Groenhout, K. M., Huijgens, P. C., Ossenkoppele, G. J., Nauta, J. J. P., & Heimans, J. J. (1992) · Archives of Neurology · doi:10.1001/archneur.1992.00530340043016 · Cited by 46
Argyriou, A. A., Polychronopoulos, P., Iconomou, G., Koutras, A., Kalofonos, H. P., & Chroni, E. (2005) · Journal of Neurology · doi:10.1007/s00415-005-0887-8 · Cited by 45
Self-citationHow far do patients with sensory ataxia benefit from so-called “proprioceptive rehabilitation”?
Missaoui, B., & Thoumie, P. (2009) · Neurophysiologie Clinique · doi:10.1016/j.neucli.2009.07.002 · Cited by 44
Exacerbation of oxaliplatin neurosensory toxicity following surgery
Gornet, J., Savier, É., Lokiec, F. M., Cvitkovic, E., Misset, J. L., & Goldwasser, F. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf254 · Cited by 43
Lhermitte's sign as a complication of cisplatin-containing chemotherapy for testicular cancer.
Eeles, R. A., Dm, T., & Mj, P. (1986) · PubMed · Cited by 38
Antonacopoulou, A. G., Argyriou, A. A., Scopa, C. D., Kottorou, A. E., Kominea, A., Peroukides, S., & Kalofonos, H. P. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02966.x · Cited by 37
Self-citationNeuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas
Grouzmann, E., Gicquel, C., Plouin, P., Schlumberger, M. J., Comoy, E., & Bohuon, C. (1990) · Cancer · doi:10.1002/1097-0142(19901015)66:8<1697::aid-cncr2820660808>3.0.co;2-g · Cited by 36
Kanai, M., Yoshioka, A., Tanaka, S., Nagayama, S., Matsumoto, S., Nishimura, T., Niimi, M., Teramukai, S., Takahashi, R., Mori, Y., et al. (2010) · Cancer Epidemiology · doi:10.1016/j.canep.2010.02.008 · Cited by 33
Jehn, C., Boulikas, T., Kourvetaris, A., Kofla, G., Possinger, K., & Lüftner, D. (2008) · PubMed · Cited by 31
Chon, H. J., Rha, S. Y., Im, C. K., et al. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.196 · Cited by 28
Jehn, C., Siebmann, S., Pecher, G., Wernicke, K., Possinger, K., & Lüftner, D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.6040 · Cited by 27
Broun, G. O., Blessing, J. A., Eddy, G. L., & ADELSON, M. D. (1993) · American Journal of Clinical Oncology · doi:10.1097/00000421-199302000-00005 · Cited by 25
Earl, H. M., Connolly, S., Latoufis, C., Eagle, K., Ash, C. M., Fowler, C. J., & Souhami, R. L. (1998) · Sarcoma · doi:10.1080/13577149878055 · Cited by 24
Liao, C., Li, J., Bin, Q., Cao, Y., & Gao, F. (2009) · International Journal of Colorectal Disease · doi:10.1007/s00384-009-0838-4 · Cited by 18
Druker, B. J., Rosenthal, D. S., & Canellos, G. P. (1989) · Cancer · doi:10.1002/1097-0142(19890315)63:6<1060::aid-cncr2820630603>3.0.co;2-m · Cited by 18
Treatment of advanced non-small cell lung cancer (NSCLC): The ‘Umbria’ cooperative study
Crinò, L., Darwish, S., Corgna, E., Meacci, M. L., Costanzo, F. D., Buzzi, F., Fornari, G., Santi, F., Ballatori, E., & Luccioli, L. (1989) · Lung Cancer · doi:10.1016/0169-5002(89)90133-5 · Cited by 14
Cited by
Hershman, D. L., Lacchetti, C., Dworkin, R. H., Lavoie Smith, E. M., Bleeker, J., Cavaletti, G., Chauhan, C., Gavin, P., Lavino, A., Lustberg, M. B., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.0914 · Cited by 1,209
Self-citationSmith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
American Cancer Society Colorectal Cancer Survivorship Care Guidelines
El‐Shami, K., Oeffinger, K. C., Erb, N. L., Willis, A., Bretsch, J. K., Pratt‐Chapman, M. L., Cannady, R. S., Wong, S. L., Rose, J., Barbour, A. L., et al. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21286 · Cited by 475
Chemotherapy Side-Effects: Not All DNA Damage Is Equal
van den Boogaard, W. M. C., Komninos, D. S. J., & Vermeij, W. P. (2022) · Cancers · doi:10.3390/cancers14030627 · Cited by 458
Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
Areti, A., Yerra, V. G., Naidu, V., & Kumar, A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.006 · Cited by 456
Metadata
- Authors
- Argyriou, A. A., Bruna, J., Marmiroli, P., & Cavaletti, G.
- Venue
- Critical Reviews in Oncology/Hematology
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 82
- Issue
- 1
- Pages
- 51-77
- ISSN
- 1040-8428 (ISSN-L)
- OpenAlex
- W2079378158
- Cited by
- 568
- References
- 180
- FWCI
- 11.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.